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Abstract
Food-responsive enteropathy (FRE), idiopathic inflammatory bowel disease (IBD), and alimen-
tary tract lymphoma (AL) are often the remaining differentials for cats presenting with chronic
gastrointestinal (GI) signs. Differential diagnosis is further complicated by overlapping clini-
copathological features and histopathological changes, however.
In this study we describe the clinical presentation of cats with chronic GI signs secondary to FRE,
IBD, and AL, and evaluate possible associations between clinical, clinicopathological, ultrasono-
graphic findings and diagnosis.
The medical records of client-owned cats with chronic GI signs secondary to FRE, IBD, and AL
were reviewed. Univariate and multivariate logistic regression models and receiver-operating charac-
teristic curve (ROC) analysis were used for testing the data.
Of the 56 cats included in the study, 22 were diagnosed with FRE (mean age, 70 months ± 49), 17
with IBD (mean age, 101 months ± 40), and 17 with AL (mean age, 122 months ± 45). Cats with FRE
were younger and presented more often with diarrhea and less frequently with muscle wasting than
cats with IBD or AL. In cats with AL, serum cobalamin levels were lower than in those with FRE or
IBD (239 ± 190 ng/L vs. 762 ± 408 ng/L and 625 ± 443 ng/L, respectively) and folate levels were higher
than in cats with IBD (18.2 ± 4.2 μg/L vs. 9.1 ± 4.7 ,g/L, respectively). Multivariate/ROC curve analysis
showed increased values of BUN (sensitivity 100, specificity 29.4, criterion >37 mg/dl) and serum
folate (sensitivity 80, specificity 100, criterion >15.6 μg/L) and reduced values of cobalamin (sensitivity
100, specificity 62.5, criterion ≤540 ng/L), which suggested a diagnosis of AL versus IBD.
Some clinicopathological features evaluated at diagnosis might suggest AL; however, because
differentiating AL from IBD is often difficult, definitive diagnosis should be based on invasive diag-
nostic workup.
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Introduction
Chronic clinical signs of gastrointestinal (GI) dis-
ease are a common presenting complaint in cats of all
ages; however, such manifestations are not disease-spe-
cific and frequently overlap with other non GI-dis-
orders (Jergens 2012). After excluding the possibility of
infectious/parasitic agents, non GI-disorders, exocrine
pancreatic insufficiency, and abnormalities requiring
surgery, the remaining differentials include food-re-
sponsive enteropathy (FRE), idiopathic inflammatory
bowel disease (IBD), and alimentary lymphoma (AL)
(Guilford et al. 1998, Guilford et al. 2001, Janeczko et
al. 2008, Krick et al. 2008, Lingard et al. 2009,
Washabau et al. 2010, Barrs and Beatty 2012, Jergens
2012). While dietary trials will usually rule out FRE
(Guilford et al. 2001, Trepanier 2009, Mandigers and
German 2010), differentiation of IBD from small-cell
AL poses a diagnostic challenge because histological
features can overlap (Waly et al. 2005, Briscoe et al.
2011, Kiupel et al. 2011) and because small-cell AL and
inflammatory infiltrates can coexist (Briscoe et al. 2011,
Kiupel et al. 2011). Other factors that may lead to mis-
diagnosis include the potential for IBD to progress to
AL (Davenport et al. 1987, Hart et al. 1994), differen-
ces in histopathologic evaluation among pathologists
(Willard et al. 2002), inadequacy of endoscopic biopsy
specimens, and incorrect anatomic sampling from the
GI tract (Evans et al. 2006, Kleinschmidt et al. 2010,
Kiupel et al. 2011). Differentiation between IBD and
AL relies on a diagnostic approach that combines mor-
phologic with immunohistochemical and clonality
analysis (Moore et al. 2005, Waly et al. 2005, Kiupel
et al. 2011).
Studies comparing IBD and AL are numerous
(Waly et al. 2005, Evans et al. 2006, Kleinschmidt et
al. 2010, Zwingenberger et al. 2010, Briscoe et al.
2011, Kiupel et al. 2011, Scott et al. 2011, Swanson et
al. 2012, Al-Ghazlat et al. 2013, Burke et al. 2013,
Daniaux et al. 2014); however, to the authors’ knowl-
edge, information comparing clinical, clini-
copathological data and ultrasonographic findings in
cats with chronic GI disease is scattered or lacking
(Ruaux et al. 2005, Jugan and August 2017). To fill
this gap, the present study describes the clinical pres-
entation of cats with chronic GI disease secondary to
FRE, IBD and AL, and evaluates possible associ-
ations between clinical, clinicopathological data, and
ultrasonographic findings.
Materials and Methods
The medical records of cats with chronic GI signs
of FRE, IBD, and AL diagnosed at the Veterinary
Teaching Hospitals of Bologna, Teramo, and Turin
Universities, Italy, between June 2008 and December
2013 were retrospectively reviewed. Information
gleaned from the medical records included breed, sex,
age, body condition score (BCS, 1 to 5), com-
plaints/clinical signs, cell blood count, serum biochem-
istry profile, feline immunodeficiency virus/feline
leukemia virus (FIV/FeLV) status (SNAP® FIV,
FeLV Combo, IDEXX), serum folate and cobalamin
concentrations, abdominal ultrasound changes [(in-
creased GI wall thickness, loss of GI layering, lym-
phadenomegaly) according to a modified scoring sys-
tem (Ripolle`s et al. 2013)], type of GI biopsy (endo-
scopic vs full-thickness), GI cytological/his-
topathological findings, clonality of GI lymphoid infil-
trates, treatment, response to treatment (persistence,
complete or partial remission of clinical signs), defini-
tive diagnosis (FRE, IBD, AL) and follow-up (alive
vs. date and cause of death). Cats with infectious dis-
orders, non GI-disorders, exocrine pancreatic insuffi-
ciency and/or abnormalities requiring surgery were ex-
cluded, as were cats treated with immunosuppressive
therapy before intestinal biopsy. The instrument used
to evaluate cell blood count was an ADVIA 120 He-
matology System (Siemens Healthcare, Germany), in
addition to cytological blood smear evaluation. Instru-
ments used for serum biochemistry profile evaluation
were ILab Aries Instrumentation Laboratory (IL,
Italy), and an AU400 Chemistry Analyzer (Beckman
Coulter, Italy). The reference ranges reported by the
clinical laboratories were similar. In all cats in which
histologic examination was performed, the procedure
was compliant with the histopathological standards of
the World Small Animal Veterinary Association
(WSAVA) Gastrointestinal Standardization Group.
With regard to definitive diagnosis, cats that respon-
ded to hydrolysed protein or restricted antigen diets
fed for at least 7 days (clinical signs resolved) were
categorized as having FRE (Guilford et al. 2001). Cats
with chronic (≥ 2 weeks) persistent or recurrent GI
tract signs, inadequate response to dietary (hy-
drolysed protein or restricted antigen diets fed for at
least 7 days), antimicrobial (metronidazole 15 mg/kg
PO, SID for 14 days) or anthelmintic (fenbendazole
50 mg/kg PO, SID for 5 days) trials alone, his-
topathologic evidence of mucosal inflammation, ab-
sence of other causes of GI signs/inflammation and
clinical response to prednisolone (1 mg/kg PO, SID
for at least 2 weeks before considering dose reduc-
tion) were categorized as having IBD (Al-Ghazlat et
al. 2013). In some cases in which the histopathologic
examination was not performed, the clinical response
to prednisolone and follow-up information were con-
sidered suggestive of IBD. Endoscopic or full-thick-
ness biopsies of the GI tract had been obtained to
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assess disruption of normal architecture by neoplastic
infiltrates. Endoscopic and exploratory laparotomy
procedures were performed under general anesthesia
in all cats. Anesthesia protocols were individualized.
Gastroduodenoscopy and colonoscopy to obtain GI
tract biopsy specimens were performed by some of the
authors in standardized fashion (Sum and Ward 2009)
using a flexible-video gastroscope (6 mm x 100 cm
Pentax EG1840). Mucosal surfaces of the esophagus,
stomach, duodenum and colon were evaluated and
multiple representative specimens were obtained for
histologic evaluation. Exploratory laparotomy was
performed by different staff surgeons and full-thick-
ness biopsy specimens of the stomach, duodenum,
jejunum and ileum were obtained. In addition, liver,
pancreas and enteric lymph nodes with grossly abnor-
mal appearance were biopsied. The biopsy sites and
abdominal incision were closed routinely. Pos-
toperative care was routine. In selected cases, aspir-
ation cytology of focal intestinal wall masses or en-
larged mesenteric lymph nodes was considered ad-
equate to diagnose high-grade AL or large granular
AL (Barrs and Beatty 2012). To more accurately dif-
ferentiate severe forms of IBD from small-cell AL,
the histological findings and results of immunopheno-
type and clonality analysis were combined (Kiupel et
al. 2011, Barrs and Beatty 2012), along with response
to therapy and follow-up information (Barrs and Be-
atty 2012, Jergens 2012). Endoscopic and full-thick-
ness biopsy samples were formalin fixed and paraf-
fin-embedded. Serial sections from paraffin tissue
blocks from each sample were cut for routine hema-
toxylin and eosin (HE) staining, and subsequently de-
paraffinized for DNA extraction and PCR amplifica-
tion in order to detect rearrangements of T and B cell
variable regions.
Statistical analysis
Statistical analysis was performed with a commer-
cially available program (MedCalc®). Values of
p<0.05 were considered significant. Assessment of
data for normality was calculated by applying the
D’Agostino-Pearson test. Data are expressed as mean
(± standard deviation [SD]) or median (95% confi-
dence interval [95% CI]). Complaints/clinical signs
(vomiting, diarrhea, changes in appetite, weight loss,
muscle wasting, icterus, pruritus, attitude/activity)
were reported in a dichotomous manner (0, not pres-
ent; 1, present) and were compared by applying
a chi-square test. The following parameters at inclu-
sion [sex, age, BCS, packed cell volume, white blood
cell count, platelets, blood urea nitrogen, serum total
protein, albumin, globulin, total cholesterol, alanine
aminotransferase, alkaline phosphatase, γ-glutamil-
transferase, total bilirubin, phosphorus, sodium, cal-
cium, serum cobalamin, serum folate, FIV/FeLV
status and abdominal ultrasound changes (GI wall
thickening, loss of GI layering, lymphadenomegaly)]
were compared using one-way-analysis of variance
(ANOVA) or a Kruskall-Wallis test and a post hoc
test (Student-Newman-Keuls test or Dunns test).
Univariate logistic regression was performed on the
data from cats with IBD and AL to screen for poten-
tial predictors for subsequent inclusion in a multivari-
able model. Variables with a value <0.15 at univariate
analysis were entered in a final model-building pro-
cess using a forward conditional method. The vari-
ables were then removed one at a time until the
model with the best fit was identified. A receiver-op-
erating characteristic (ROC) curve was used to select
the optimum cut-off value of significant variables in
the multivariate analysis to discriminate cats with IBD
from those with AL.
Results
History and physical examination
The medical records of 56 client-owned cats with
chronic GI signs secondary to FRE, IBD or AL diag-
nosed between June 2008 and December 2013 were
reviewed. The group of 22 cats with FRE included
9 males (8 neutered) and 13 females (9 spayed) and
ranged in age from 5 to 190 months (mean, 70 ± 49).
Breeds included 1 each of Chartreux, Norwegian For-
est, Persian, Ragdoll, Siamese and Sphynx, and 16
European Shorthair cats. The group of 17 cats with
IBD included 9 males (7 neutered) and 8 females (6
spayed) and ranged in age from 36 to 176 months
(mean, 101 ± 40). Breeds included 1 each of Maine
Coon, Persian, and Scottish Fold cats, and 14 Euro-
pean Shorthair cats. The group of 17 cats with AL
included 11 males (9 neutered) and 6 spayed females
and ranged in age from 30 to 172 months (mean, 122
± 45). Breeds included 1 each of Persian and Maine
Coon, and 15 European Shorthair cats. There was no
statistically significant difference in sex between the
three groups. Cats with FRE were significantly
younger than those with IBD or AL (p<0.01) and
presented more often with diarrhea and less often
with muscle wasting than the other two groups. Table
1 reports the complaints/clinical signs and BCS of the
three groups.
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Table 1. List of presenting complaints/clinical signs and BCS scores in cats with FRE, IBD, and AL.
Variable FRE (n=22) IBD (n=17) AL (n=17)
Vomiting (%) 54.5 76.5 70.6
Diarrhea (%) 81.8 47 47
Decreased appetite (%) 13.6 23.5 5.9
Increased appetite (%) 50 47 58.8
Weight loss (%) 54.5 70.6 82.3
Muscle wasting (%) 31.8 58.8 76.5
Icterus (%) 4.5 11.8 –
Pruritus (%) 4.5 5.9 5.9
Reduced attitude/activity (%) 54.5 52.9 29.4
BCS (mean ± SD) 2.8 ± 1 3.1 ± 1.7 2.3 ± 1.2
n=number of cats
FRE – denotes food-responsive enteropathy; IBD – inflammatory bowel disease; AL – alimentary tract lymphoma; BCS – body
condition score
Table 2. Laboratory findings in cats with FRE, IBD, and AL.
Variable FRE (n=22) IBD (n=17) AL (n=17)
Variable Mean (± SD) Mean (± SD) Mean (± SD) Reference values
PCV 36.1 (± 4.6) % 32.9 (± 9.4) % 33.7 (± 10.3) % 27.7-46.8%
WBC 12,771 (± 7,936)
cells/μL
14,758 (± 11,272)
cells/μL
19,744 (± 12,854)
cells/μL
6,300-19,600
cells/μL
Platelets 366,832 (± 139,462)
cells/μL
656,156 (± 114,056)
cells/μL
344,069 (± 226,864)
cells/μL
156,400-626,4000
cells/μL
Blood Urea Nitrogen 62 (± 35) mg/dL 52 (± 19) mg/dL 66 (± 25) mg/dL 43-64 mg/dL
Total Protein 6.9 (± 1.0) g/dL 6.9 (± 1.4) g/dL 6.3 (± 1.3) g/dL 5.4-7.8 g/dL
Albumin 3.0 (± 0.7) g/dL 2.8 (± 0.7) g/dL 2.8 (± 0.5) g/dL 3.0-4.6 g/dL
Globulin 4.0 (± 0.9) g/dL 4.0 (± 1.3) g/dL 3.5 (± 0.7) g/dL 2.4-3.2 g/dL
Total Cholesterol 156 (± 66) mg/dL 168 (± 79) mg/dL 119 (± 45) mg/dL 95-130 mg/dL
Alanine Aminotransferase 450 (± 146) U/L 95 (± 97) U/L 68 (± 47) U/L 30-100 U/L
Alkaline Phosphatase 191 (± 123) U/L 46 (± 36) U/L 54 (± 40) U/L 25-93 U/L
Gamma Glutamyl Transferase 1.3 (± 3.1) U/L 1.1 (± 2.2) U/L 0.4 (± 0.6) U/L 1.3-5.1 U/L
Total Bilirubin 0.14 (± 0.07) mg/dL 0.21 (± 0.15) mg/dL 0.10 (± 0.10) mg/dL 0.15-0.20 mg/dL
Phosphorus 5.12 (± 1.5) 4.37 (± 1.5) 4.10 (± 0.90) 4.5-8.1 mg/dL
Sodium 151 (± 5) mEq/L 149 (± 6) mEq/L 150 (± 4) mEq/L 153-162 mEq/L
Potassium 4.5 (± 0.6) mEq/L 4.1 (± 1.2) mEq/L 4.3 (± 0.5) mEq/L 3.6-5.8 mEq/L
Total Calcium 9.8 (± 0.9) mg/dL 9.5 (± 0.8) mg/dL 9.2 (± 0.9) mg/dl 6.2-10.2 mg/dL
Cobalamin 762 (± 408) ng/L 625 (± 443) ng/L 239 (± 190) ng/L 290-1500 ng/L
Folate 12.9-6.1 μg/L 9.1 (± 4.7) μg/L 18.2 (± 4.2) μg/L 9.5-21.5 μ/L
n=number of cats
PCV – denotes packed cell volume; WBC – white blood cell
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Table 3. Selected haematological, biochemical and SNAP test variables tested in cats with FRE, IBD, and AL.
Variable FRE (n=22) IBD (n=17) AL (n=17)
Sodium 77.3 100 88.2
Variable % % %
Potassium 77.3 100 88.2
PCV 86.4 100 100
Total Calcium 77.3 94.1 88.2
WBC 86.4 94.1 94.1
Cobalamin 63.6 47 35.3
Platelets 86.4 94.1 94.1
Folate 63.6 47 29.4
Blood Urea Nitrogen 81.8 100 100
FeLV SNAP® 90.9 64.7 64.7
Total Protein 81.8 100 100
FIV SNAP® 95.4 70.6 70.6
Albumin 77.3 100 100
Globulin 72.7 100 100
Total Cholesterol 72.7 94.1 88.2
Alanine Aminotransferase 81.8 100 100
Alkaline Phosphatase 81.8 100 100
Gamma Glutamyl Transferase 81.8 94.1 94.1
Total Bilirubin 81.8 100 88.2
Phosphorus 77.3 94.1 88.2
n = number of cats
FRE – denotes food-responsive enteropathy; IBD – inflammatory bowel disease; AL – alimentary tract lymphoma; PCV
– packed cell volume; WBC – white blood cell; FeLV SNAP® – feline leukemia virus test (Idexx); FIV SNAP® – feline
immunodeficiency virus test (Idexx).
Clinicopathologic findings
Data regarding clinicopathological abnormalities
and the number of cats that had undergone testing are
shown in Tables 2 and 3, respectively. Among the cats
with known FIV (45/56) and FeLV (42/56) status,
1 with IBD tested positive for FIV and 1 with AL
tested positive for FeLV. Serum cobalamin levels
were lower in cats with AL than in those with FRE or
IBD (239 ± 190 ng/L vs. 762 ± 408 ng/L and 625 ± 443
ng/L, respectively); and serum folate levels were high-
er in cats with AL than in those with IBD (18.2 ± 4.2
μg/L vs. 9.1 ± 4.7 μg/L, respectively). Multivariate/
ROC curve analysis showed increased values for BUN
(sensitivity 100, specificity 29.4, criterion >37 mg/dl)
and serum folate (sensitivity 80, specificity 100, cri-
terion >15.6 μg/L) and reduced values for cobalamin
(sensitivity 100, specificity 62.5, criterion ≤ 540 ng/L),
which suggested a diagnosis of AL vs. IBD.
Abdominal ultrasonographic findings
Abdominal ultrasonography findings were re-
ported for 13/22 cats with FRE, 15/17 with IBD, and
17/17 with AL. GI wall thickening was detected in
7/22 cats with FRE, 7/17 with IBD, and 7/17 with AL;
loss of GI layering was detected in 5/22 cats with FRE,
2/17 with IBD, and 4/17 with AL; lymphadenomegaly
was detected in 4/22 cats with FRE, 4/17 with IBD,
and 5/17 with AL. There were no significant differen-
ces in ultrasonographic findings between the three
groups.
Gastrointestinal cytology/histopathology results,
and clonality
Gastroduodenoscopy was performed in 9 cats
(1 with FRE, 4 with IBD, and 4 with AL), followed by
Evaluation of clinicopathological features... 407
Unauthenticated
Download Date | 9/2/17 2:35 PM
colonoscopy in 2 cats with IBD and in 1 with AL.
Laparotomy was performed in 37 cats (13 with FRE,
11 with IBD, and 13 with AL). Tissue quality was
classified as adequate in all cases. The most common
abnormalities in the cats with IBD were lymphocytic
plasmacytic (n=13 cats), eosinophilic (n=1 cat), and
mixed lymphocytic plasmacytic and eosinophilic in-
flammation (n=1 cat). Low-grade AL was identified
in 12 cats, intermediate-grade AL in 2, high-grade AL
in 2, and large granular AL in 1 cat. Large granular
AL, intermediate-grade, and high-grade AL were di-
agnosed on the basis of transabdominal fine-needle
aspiration cytology of the intestinal wall and mesen-
teric lymph nodes. B- and T-cell clonality analysis was
performed in the 14 cases (5 IBD and 9 low-grade
AL) with severe lymphocytic intestinal infiltration.
The monoclonal nature of the T-cell populations was
considered neoplastic in 9 cases and polyclonal rear-
rangements were detected in 5. There was no dis-
agreement between histopathologic findings and
clonality analysis results within the groups.
Response to therapy and follow-up
All 22 cats with FRE received a hydrolysed (8
cats) or a restricted antigen diet (14 cats), with com-
plete remission of clinical signs achieved in all but
2 cats which then underwent a second dietary trial
with a different restricted antigen diet. At the time of
medical record review (February 2015; 80 months) all
FRE cats were alive and asymptomatic. All 17 cats
with IBD received a highly digestible, hydrolysed or
restricted antigen diet in addition to prednisolone (1
mg/kg PO q12h for at least 2 weeks before considering
dose reduction). Complete or partial remission of cli-
nical signs was achieved in all cats. In the cats with
partial remission, combined therapy with pred-
nisolone and metronidazole (15 mg/kg PO q24h) was
administered to achieve complete remission of clinical
signs. At the time of medical record review, 5/17 cats
with IBD were dead or had been euthanized (median
survival time, 0.4-12 months, 95% Confidence Interval
[CI] 5.5) and the remaining 12 cats were alive and
asymptomatic or paucisymptomatic. The most fre-
quent cause of death or reason for euthanasia was
deterioration of clinical conditions reportedly due to
malabsorption. Two of the 17 cats with AL (1 with
high-grade AL and 1 with large granular AL) were
euthanized at diagnosis upon owner request. The re-
maining 15 cats underwent various chemotherapy pro-
tocols [CHOP (Hydroxydaunorubicin, Oncovin-vin-
cristine, Prednisolone) or COP (Cyclophosphamide,
Oncovin-vincristine, Prednisolone)-based protocols;
prednisolone and chlorambucil]. Four of these cats
died (high-grade AL in 1, intermediate-grade AL in 1,
low-grade AL in 2) within 2 to 24 weeks of diagnosis.
The duration of remission in the remaining 11 cats (all
with low-grade AL) varied widely (median duration,
2.9 to 24.5 months, 95% CI 15) and were all dead at
the time of medical record review. Regardless of the
diagnosis, parenteral cobalamin supplementation was
given to all cats with subnormal cobalamin levels.
Discussion
This retrospective multicenter study compares, for
the first time, clinical, clinicopathological data and
ultrasonographic findings in cats with GI signs caused
by FRE, IBD, and AL, and investigates potential as-
sociations with diagnosis. Consistent with previous ob-
servations, the cats with FRE were significantly
younger than those with IBD or AL (Guilford et al.
2001, Jergens 2012, Al-Ghazlat et al. 2013). Although
sex (male) and breed (Siamese and other Asian
breeds) are known to predispose for AL and IBD,
respectively (Guilford 1996, Fondacaro et al. 1999),
we found no significant differences in the occurrence
of either disease in relation to sex or breed. Cats with
FRE, IBD and AL may present with any combination
of weight loss, changes in appetite, vomiting, lethargy,
and diarrhea (Guilford et al. 2001, Jergens 2012,
Al-Ghazlat et al. 2013). We observed that weight loss
was the most common presenting complaint/clinical
sign, followed by vomiting and diarrhea, and that the
cats with FRE presented more often with diarrhea
and less often with muscle wasting than those with
IBD or AL. Taken together, these results suggest that
young-adult cats with a chronic history of weight loss,
diarrhea, and minimal muscle wasting may potentially
be affected by FRE.
In veterinary medicine, decreased serum co-
balamin and folate concentrations are routinely used
as a marker of GI absorptive dysfunction, distal and
proximal, respectively (Simpson et al. 2001, Reed et
al. 2007, Ruaux 2008, Berghoff and Steiner 2011),
while increased serum folate concentrations may sug-
gest small intestine dysbiosis (Ruaux et al. 2005). Pre-
vious studies have variously documented the preva-
lence of hypocobalaminemia in cats with GI disease
(Simpson et al. 2001, Ibarrola et al. 2005, Reed et al.
2007, Barron et al. 2009). Moreover, failure to recog-
nize and correct hypocobalaminemia can delay clini-
cal recovery, even when specific therapy for IBD is
instituted (Ruaux et al. 2005). In the present study,
the serum cobalamin levels were lower in the cats with
AL than in those with FRE or IBD and the serum
folate concentrations were higher than in those with
IBD. Although more sensitive measurements of clini-
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cal hypocobalaminemia have been investigated in cats
(Ruaux et al. 2009), the results of this study suggest
that AL causes severe absorptive intestinal dysfunc-
tion and dysbiosis and that serum cobalamin is a prac-
tical indicator of severe gastrointestinal disease, such
as AL (Simpson et al. 2001). In the majority of healthy
cats, the cobalamin level is ≥500 ng/L (Ruaux et al.
2001, 2009, Maunder et al. 2012) and <500 ng/L in
most cats with GI disease, regardless of the diagnosis
(Simpson et al. 2001). In this study, AL could be ruled
out with a serum cobalamin level ≤540 ng/L.
An ultrasonographic pattern of muscularis propria
thickening has been recognized in cats with low-grade
AL and IBD (Lingard et al. 2009, Zwingenberger et
al. 2010), while intermediate and low-grade AL typi-
cally cause single or multiple masses in the stomach,
intestines or colon (Penninck et al. 1994). However,
the absence of abnormal findings at ultrasonography
does not exclude inflammatory/neoplastic infiltrations
(Daniaux et al. 2014). More recently, no differences in
wall-layering were found when the two diseases were
compared (Daniaux et al. 2014). Similarly, we found
no significant differences in ultrasonographic findings
between the three groups.
The major limitation of this study is its retrospec-
tive nature. Furthermore, each cat was examined by
a variable number of clinicians and ultrasonographers.
Finally, the diagnostic procedures were not strictly
standardized and not all cats underwent endos-
copy/laparotomy and clonality testing. It should be
noted, however, that the response to therapy and the
long-term follow-up supported the clinicians in mak-
ing the final diagnosis.
In conclusion, adult and elderly cats with muscle
wasting, increased values of BUN and serum folate
and reduced values of cobalamin at presentation may
suffer from AL. However, the definitive diagnosis
should always be based on the evaluation of clinical
signs, invasive diagnostic workup, response to therapy,
and findings at follow-up.
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